Aug. 14 at 10:28 PM
$PYPD
Here's a little bit of weekend hype for you.
One of our biggest worries going forward is CMC issues.
But we do know that both of the companies PolyPid was in talks with for a partnership did mock inspections of the manufacturing facility.
There have also been a couple of successful inspections by the Israeli Ministry of Health, which is another plus.
Azurity already has a significant GI presence, including SUTAB and SUFLAVE (they've gotten 4 million prescriptions for this in the past 2 years), and they're already dealing with the doctors and practices that are seeing these colorectal patients.
See what they're building here? It's not just a random drug they're adding.
It's a suite of products around the GI/colorectal space... Pre-surgery prep, post surgery risk reduction.
